Ex Vivo Expanded Donor Alloreactive Regulatory T Cells Lose Immunoregulatory, Proliferation, and Antiapoptotic Markers After Infusion Into ATG-lymphodepleted, Nonhuman Primate Heart Allograft Recipients

被引:17
作者
Ezzelarab, Mohamed B. [1 ]
Zhang, Hong [1 ]
Sasaki, Kazuki [1 ]
Lu, Lien [1 ]
Zahorchak, Alan F. [1 ]
van der Windt, Dirk J. [1 ]
Dai, Helong [1 ]
Perez-Gutierrez, Angelica [1 ]
Bhama, Jay K. [2 ]
Thomson, Angus W. [1 ,3 ]
机构
[1] Univ Pittsburgh, Starzl Transplantat Inst, Dept Surg, Sch Med, 200 Lothrop St,Biomed Sci Tower, Pittsburgh, PA 15235 USA
[2] Univ Pittsburgh, Dept Cardiothorac Surg, Sch Med, Pittsburgh, PA 15235 USA
[3] Univ Pittsburgh, Dept Immunol, Sch Med, Pittsburgh, PA 15235 USA
关键词
KIDNEY-TRANSPLANTATION; RABBIT ATG; REJECTION; THERAPY; PERSISTENCE; GENERATION; EXPANSION; RESPONSES; SUPPRESS; BIOLOGY;
D O I
10.1097/TP.0000000000003617
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Regulatory T cell (Treg) therapy is a promising approach to amelioration of allograft rejection and promotion of organ transplant tolerance. However, the fate of infused Treg, and how this relates to their therapeutic efficacy using different immunosuppressive regimens is poorly understood. Our aim was to analyze the tissue distribution, persistence, replicative activity and phenotypic stability of autologous, donor antigen alloreactive Treg (darTreg) in anti-thymocyte globulin (ATG)-lymphodepleted, heart-allografted cynomolgus monkeys. Methods. darTreg were expanded ex vivo from flow-sorted, circulating Treg using activated donor B cells and infused posttransplant into recipients of major histocompatibility complex-mismatched heart allografts. Fluorochrome-labeled darTreg were identified and characterized in peripheral blood, lymphoid, and nonlymphoid tissues and the graft by flow cytometric analysis. Results. darTreg selectively suppressed autologous T cell responses to donor antigens in vitro. However, following their adoptive transfer after transplantation, graft survival was not prolonged. Early (within 2 wk posttransplant; under ATG, tacrolimus, and anti-IL-6R) or delayed (6-8 wk posttransplant; under rapamycin) darTreg infusion resulted in a rapid decline in transferred darTreg in peripheral blood. Following their early or delayed infusion, labeled cells were evident in lymphoid and nonlymphoid organs and the graft at low percentages (<4% CD4(+) T cells). Notably, infused darTreg showed reduced expression of immunoregulatory molecules (Foxp3 and CTLA4), Helios, the proliferative marker Ki67 and antiapoptotic Bcl2, compared with preinfusion darTreg and endogenous CD4(+)CD25(hi) Treg. Conclusions. Lack of therapeutic efficacy of infused darTreg in lymphodepleted heart graft recipients appears to reflect loss of a regulatory signature and proliferative and survival capacity shortly after infusion.
引用
收藏
页码:1965 / 1979
页数:15
相关论文
共 40 条
[11]   Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro [J].
Feng, Xingmin ;
Kajigaya, Sachiko ;
Solomou, Elena E. ;
Keyvanfar, Keyvan ;
Xu, Xiuli ;
Raghavachari, Nalini ;
Munson, Peter J. ;
Herndon, Thomas M. ;
Chen, Jichun ;
Young, Neal S. .
BLOOD, 2008, 111 (07) :3675-3683
[12]   mTOR Inhibitor Everolimus in Regulatory T Cell Expansion for Clinical Application in Transplantation [J].
Gedaly, Roberto ;
De Stefano, Felice ;
Turcios, Lilia ;
Hill, Marita ;
Hidalgo, Giovanna ;
Mitov, Mihail I. ;
Alstott, Michael C. ;
Butterfield, D. Allan ;
Mitchell, Hunter C. ;
Hart, Jeremy ;
Al-Attar, Ahmad ;
Jennings, Chester D. ;
Marti, Francesc .
TRANSPLANTATION, 2019, 103 (04) :705-715
[13]   Generation, cryopreservation, function and in vivo persistence of ex vivo expanded cynomolgus monkey regulatory T cells [J].
Guo, Hao ;
Zhang, Hong ;
Lu, Lien ;
Ezzelarab, Mohamed B. ;
Thomson, Angus W. .
CELLULAR IMMUNOLOGY, 2015, 295 (01) :19-28
[14]   Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20/CDI9-Specific Chimeric Antigen Receptor Redirected T Cells in Humans [J].
Jensen, Michael C. ;
Popplewell, Leslie ;
Cooper, Laurence J. ;
DiGiusto, David ;
Kalos, Michael ;
Ostberg, Julie R. ;
Forman, Stephen J. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (09) :1245-1256
[15]   CD4+CD25+ regulatory T cells in transplantation:: Progress, challenges and prospects [J].
Kang, S. M. ;
Tang, Q. ;
Bluestone, J. A. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (06) :1457-1463
[16]   Translational impact of NIH-funded nonhuman primate research in transplantation [J].
Knechtle, Stuart J. ;
Shaw, Julia M. ;
Hering, Bernhard J. ;
Kraemer, Kristy ;
Madsen, Joren C. .
SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (500)
[17]   CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells [J].
Kowolik, Claudia M. ;
Topp, Max S. ;
Gonzalez, Sergio ;
Pfeiffer, Timothy ;
Olivares, Simon ;
Gonzalez, Nancy ;
Smith, David D. ;
Forman, Stephen J. ;
Jensen, Michael C. ;
Cooper, Laurence J. N. .
CANCER RESEARCH, 2006, 66 (22) :10995-11004
[18]   A Clinical Trial With Adoptive Transfer of Ex Vivo-induced, Donor-specific Immune-regulatory Cells in Kidney Transplantation-A Second Report [J].
Koyama, Ichiro ;
Bashuda, Hisashi ;
Uchida, Koichiro ;
Seino, Ken-ichiro ;
Habu, Sonoko ;
Nakajima, Ichiro ;
Fuchinoue, Shohei ;
Okumura, Ko ;
Teraoka, Satoshi .
TRANSPLANTATION, 2020, 104 (11) :2415-2423
[19]   Harnessing Advances in T Regulatory Cell Biology for Cellular Therapy in Transplantation [J].
Lam, Avery J. ;
Hoeppli, Romy E. ;
Levings, Megan K. .
TRANSPLANTATION, 2017, 101 (10) :2277-2287
[20]   Guiding regulatory T cells to the allograft [J].
Lamarche, Caroline ;
Levings, Megan K. .
CURRENT OPINION IN ORGAN TRANSPLANTATION, 2018, 23 (01) :106-113